World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
21364
World Ranking
15768
National Ranking
78

Overview

Thomas H. Helbich is affiliated with the Medical University of Vienna in Austria. Their work primarily spans the field of Medicine, with a significant focus on Radiology, Nuclear Medicine and Imaging. Additional subfields include Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research, and Oncology.

Their research covers a variety of topics, notably MRI in cancer diagnosis, Radiomics and Machine Learning in Medical Imaging, and Medical Imaging Techniques and Applications. Other key areas include Breast Lesions and Carcinomas, Advanced MRI Techniques and Applications, Breast Cancer Treatment Studies, and the application of AI in cancer detection.

Frequent publication venues for Thomas H. Helbich include:

  • European Radiology
  • European Journal of Radiology
  • Cancers
  • Senologie - Zeitschrift für Mammadiagnostik und -therapie
  • International Journal of Molecular Sciences

The scientist often collaborates with several co-authors, including:

  • Pascal Baltzer
  • Paola Clauser
  • Katja Pinker
  • Panagiotis Kapetas
  • Joachim Friske

Examples of recent papers authored or co-authored by Thomas H. Helbich are:

  • Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI), 2022, European Radiology
  • Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging, 2020, Insights into Imaging
  • Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis, 2022, Radiology
  • Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI, 2020, European Journal of Nuclear Medicine and Molecular Imaging
  • Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy, 2021, Clinical Cancer Research

Best Publications

  • Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.

    Francesco Sardanelli;Carla Boetes;Bettina Borisch;Thomas Decker

  • Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists.

    Alejandro Rodriguez-Ruiz;Kristina Lång;Albert Gubern-Merida;Mireille Broeders

  • Breast MRI: EUSOBI recommendations for women's information.

    Ritse M. Mann;Corinne Balleyguier;Pascal A. Baltzer;Ulrich Bick

  • Stereotactic breast biopsy of nonpalpable lesions : Determinants of ductal carcinoma in situ underestimation rates

    R. J. Jackman;F. Burbank;S. H. Parker;W. P. Evans

  • Diffusion-weighted MR for Differentiation of Breast Lesions at 3.0 T: How Does Selection of Diffusion Protocols Affect Diagnosis?

    Wolfgang Bogner;Stephan Gruber;Katja Pinker;Günther Grabner

  • Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density

    Christopher C. Riedl;Nikolaus Luft;Clemens Bernhart;Michael Weber

  • Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

    B. Nicolas Bloch;B. Nicolas Bloch;Edna Furman-Haran;Thomas H. Helbich;Robert E. Lenkinski

  • Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.

    Karen Kinkel;Thomas H. Helbich;Laura J. Esserman;John Barclay

  • Cystic Fibrosis: CT Assessment of Lung Involvement in Children and Adults

    Thomas H. Helbich;Gertraud Heinz-Peer;Irmgard Eichler;Patrick Wunderbaldinger

  • Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.

    Amirhessam Tahmassebi;Georg J Wengert;Thomas H Helbich;Zsuzsanna Bago-Horvath

  • US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases.

    Gerd Schueller;Sylvia Jaromi;Lothar Ponhold;Michael Fuchsjaeger

  • Readout-segmented Echo-planar Imaging Improves the Diagnostic Performance of Diffusion-weighted MR Breast Examinations at 3.0 T

    Wolfgang Bogner;Katja Pinker-Domenig;Hubert Bickel;Marek Chmelik

  • Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?

    Oswald Graf;Thomas H. Helbich;Michael H. Fuchsjaeger;Gottfried Hopf

  • Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme.

    Axel Gossmann;Thomas H. Helbich;Nagato Kuriyama;S. Ostrowitzki

  • Stereotactic 11-gauge vacuum-assisted breast biopsy: A validation study

    Georg Pfarl;Thomas H Helbich;Christopher C Riedl;Teresa Wagner

  • Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures.

    Matthew Wallis;Anne Tarvidon;Thomas Helbich;Ingrid Schreer

  • Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey

    Francesco Sardanelli;Hildegunn S. Aase;Marina Álvarez;Edward Azavedo

  • Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study

    Alejandro Rodriguez-Ruiz;Kristina Lång;Albert Gubern-Merida;Jonas Teuwen

  • Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy?

    Oswald Graf;Thomas H. Helbich;Gottfried Hopf;Claudia Graf

  • Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.

    Katja Pinker;Wolfgang Bogner;Pascal Baltzer;Stephan Gruber

Frequent Co-Authors

Siegfried Trattnig
Siegfried Trattnig Medical University of Vienna
Elizabeth A. Morris
Elizabeth A. Morris Memorial Sloan Kettering Cancer Center
Timothy P.L. Roberts
Timothy P.L. Roberts Children's Hospital of Philadelphia
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Fiona J. Gilbert
Fiona J. Gilbert University of Cambridge
Michael Gnant
Michael Gnant Medical University of Vienna
Christoph Thomssen
Christoph Thomssen University of Göttingen
Christiane K. Kuhl
Christiane K. Kuhl RWTH Aachen University
Tanja Fehm
Tanja Fehm Heinrich Heine University Düsseldorf
Richard Pötter
Richard Pötter Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn't just mean becoming a doctor. There are several related online degrees and flexible pathways into healthcare careers. For those interested in quick entry into nursing with a bachelor’s degree in another field, msn direct entry programs online allow you to earn a Master of Science in Nursing even if you aren’t a nurse yet.

If you’re looking for faster or more accessible options, you might research the easiest rn program for straightforward admission processes, or explore an accredited medical billing and coding schools online with financial aid to enter the growing field of medical administration.

For those who prefer the practical side of healthcare, an lpn program without teas test can make becoming a licensed practical nurse more approachable, removing common entrance exam barriers.

These pathways can help you join the healthcare industry quickly, often with the convenience and flexibility of online study.

Best Scientists Citing Thomas H. Helbich

Trending Scientists

Recently Published Articles